Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3633033

CCCOc1ccc(-c2nnc(-c3cccnc3)o2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 14/20 0.58
RAB9A P51151 13/20 0.58
KDM4E B2RXH2 10/20 0.58
ALDH1A1 P00352 10/20 0.58
HPGD P15428 9/20 0.58
SMN1; SMN2 Q16637 8/20 0.58
HSD17B10 Q99714 7/20 0.58
CYP3A4 P08684 3/20 0.55
CYP2C19 P33261 3/20 0.55
CYP1A2 P05177 2/20 0.55
MAPT P10636 6/20 0.52
TSHR P16473 3/20 0.52
LMNA P02545 1/20 0.52
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP19A1 P11511 1/20 0.51
TP53 P04637 5/20 0.50
HTT P42858 1/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3633226 0.96 NPC1 (0.58) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL3635099 0.91 NPC1 (0.61) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL1422694 0.89 NPC1 (0.72) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL4915802 0.85 NPC1 (0.76) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL3634018 0.85 NPC1 (0.52) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL1422514 0.84 NPC1 (0.72) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL4927268 0.83 NPC1 (0.57) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL3635392 0.83 NPC1 (0.57) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL4927459 0.82 NPC1 (0.74) NPC1RAB9AKDM4EALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL4921599 0.81 NPC1 (0.57) NPC1RAB9AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101715449-A Heterocyclic compounds and their methods of use ABBOTT LAB 2010-05-26 CN disclosed
EP-2146985-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE Abbott Laboratories (US) 2010-01-27 EP disclosed
WO-2008127464-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-10-23 WO disclosed
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255203-A1 HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE CYP11B2, AADAC, CYP11B1 NPC1 473/4885RAB9A 3859/4885KDM4E 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.